HC Wainwright Raises Replimune Group (NASDAQ:REPL) Price Target to $17.00
Replimune Group (NASDAQ:REPL – Free Report) had its target price upped by HC Wainwright from $12.00 to $17.00 in a research report report published on Friday, Benzinga reports. They currently have a buy rating on the stock. Separately, Wedbush reaffirmed an outperform rating and issued a $16.00 target price on shares of Replimune Group in […]
More Stories
ARS Wealth Advisors Group LLC Buys 6,223 Shares of Schwab US Broad Market ETF (NYSEARCA:SCHB)
ARS Wealth Advisors Group LLC increased its stake in shares of Schwab US Broad Market ETF (NYSEARCA:SCHB – Free Report)...
Stonebridge Capital Management Inc. Sells 250 Shares of Target Co. (NYSE:TGT)
Stonebridge Capital Management Inc. cut its stake in Target Co. (NYSE:TGT – Free Report) by 11.1% in the fourth quarter,...
Sendero Wealth Management LLC Buys 172 Shares of Mastercard Incorporated (NYSE:MA)
Sendero Wealth Management LLC boosted its position in Mastercard Incorporated (NYSE:MA – Free Report) by 3.8% in the 4th quarter,...
Apella Capital LLC Has $4.95 Million Stake in Vanguard S&P 500 ETF (NYSEARCA:VOO)
Apella Capital LLC increased its holdings in Vanguard S&P 500 ETF (NYSEARCA:VOO – Free Report) by 1.3% in the fourth...
Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) Shares Sold by MPS Loria Financial Planners LLC
MPS Loria Financial Planners LLC trimmed its stake in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report)...
GE Vernova (NYSE:GEV) Trading Up 1.8% Following Analyst Upgrade
GE Vernova Inc. (NYSE:GEV – Get Free Report) shares traded up 1.8% during trading on Thursday after Truist Financial raised...